QR-Code

Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients

BackgroundStage III surgically resected melanoma is a disease at high risk of recurrence. Immune checkpoint inhibitors (ICIs) and the target therapy with BRAF and MEK inhibitors significantly changed the outcome of patients with metastatic melanoma and several studies have also shown their benefit i...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Francesca Romana Di Pietro, Sofia Verkhovskaia, Rosa Falcone, Giulia Poti, Maria Luigia Carbone, Maria Francesca Morelli, Albina Rita Zappalà, Roberto Morese, Zorika Christiana Di Rocco, Gabriele Piesco, Paolo Chesi, Cristina Maria Failla, Paolo Marchetti, Federica De Galitiis
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2024-08-01
Schriftenreihe:Frontiers in Oncology
Schlagworte:
melanoma
adjuvant immunotherapy
anti-PD-1
hyperprogression disease
molecular profiling
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fonc.2024.1437325/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge